Didn't AMRN's legal team get copies of the defendant's arguments? Isn't it a failure on their part to discover these critical omissions and point them out in rebuttals and their own documents? Especially galling when people on this board found them in a matter of days, while AMRN legal had years to prepare for the trial.
Great post...I would think the first paragraph of your post is enough overrule her opinion...And she is simply too lazy to be a judge. It is clear she had made up her mind before the trial began..
Deciding issues in complicated medical subjects like the therapeutic benefits of Omega-3 by reading the literature is an almost impossible job...There a thousands of articles in the Medical and Nutritional literature and like fingerprints; no two are the same..The only thing that is really obvious is the R-I trial results..An FDA designed and proven clinical outcomes trial.
I understand FDA does not always get it right, but I would take their opinion over a lazy and non impartial Judge...Not only did she copy and paste but she did not even bother to learn the proper procedural format for a judge to express her opinion..
She is a disgrace...She already has one sanction on her short record..She should not be making decisions that effect thousands of people and hundreds of millions of dollars..
While I agree that specific statement regarding ApoB wasn't quoted, I think Amarin stated generally Kurabayashi didn't say EPA reduced ApoB. Amarin's statement is correct, whereas defendant's partial omission is misleading.
Hamoa...The defendants produced a cropped table for Kurabayashi results, which they then showed to the judge...and which significantly influenced her decision in their favor...I'd like to think this was just a mistake made by the defendants...rather than done on purpose to influence the judge's decision.
Market Data 
Markets 
AI
